Insider · CIK 0001897618
Dan Karlin
Files at DFTX (Mind Medicine (MindMed) Inc.). First filing Dec 26, 2023, latest Sep 29, 2026.
In brief
Dan Karlin files SEC Form 4 as officer and director at DFTX (Mind Medicine (MindMed) Inc.). Since Dec 26, 2023, Dan Karlin has reported 0 open-market buys worth $0 and 9 open-market sells worth $1.3M, the latest filed on Sep 29, 2026.
A track record needs three past buys with six months of prices behind them; Dan Karlin has 0, so none is measured yet.
The newest scored trade: sold $397k of DFTX on Sep 25, 2026, filed Sep 29, 2026, scored 26 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $1.1M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DFTX: Mind Medicine (MindMed) Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Mind Medicine (MindMed) Inc. | $397k 10,853 shares | -1% | - | |
| 27Weak | Mind Medicine (MindMed) Inc. | $452k 10,035 shares | -2% | +590% from low0% from high | |
| 21Weak | Mind Medicine (MindMed) Inc. | $148k 8,018 shares | -2% | +278% from low-3% from high | |
| 18Weak | Mind Medicine (MindMed) Inc. | $74k 5,600 shares | -1% | +167% from low-8% from high | |
| 18Weak | Mind Medicine (MindMed) Inc. | $75k 7,704 shares | -2% | +100% from low-4% from high | |
| 17Weak | Mind Medicine (MindMed) Inc. | $53k 7,848 shares | -2% | +40% from low-31% from high | |
| 9Weak | Mind Medicine (MindMed) Inc. | $46k 6,836 shares | -2% | - | |
| 17Weak | Mind Medicine (MindMed) Inc. | $49k 6,643 shares | -2% | - | |
| 30Weak | Mind Medicine (MindMed) Inc. | $25k 6,774 shares | -2% | +81% from low-22% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 25, 2026 | DFTX DEFINIUM THERAPEUTICS, INC. | 10,853 0.01% of outstanding | $399k | Sep 25, 2026 | $423k |
| Jun 25, 2026 | DFTX DEFINIUM THERAPEUTICS, INC. | 10,035 0.01% of outstanding | $423k | Jun 25, 2026 | $148k |
| Mar 25, 2026 | DFTX DEFINIUM THERAPEUTICS, INC. | 8,018 0.01% of outstanding | $148k | Mar 25, 2026 | $74k |
| Dec 29, 2025 | DFTX Mind Medicine (MindMed) Inc. | 5,600 0.01% of outstanding | $74k | Dec 26, 2025 | $75k |
| Sep 25, 2025 | DFTX MIND MEDICINE (MINDMED) INC. | 7,704 0.01% of outstanding | $75k | Sep 25, 2025 | $53k |
| Jun 25, 2025 | DFTX MIND MEDICINE (MINDMED) INC. | 7,848 0.01% of outstanding | $53k | Jun 25, 2025 | none |
| Mar 25, 2025 | DFTX MIND MEDICINE (MINDMED) INC. | 6,836 0.01% of outstanding | $46k | Mar 25, 2025 | $49k |
| Dec 26, 2024 | DFTX MIND MEDICINE (MINDMED) INC. | 6,643 0.01% of outstanding | $49k | Dec 26, 2024 | none |
| Mar 25, 2024 | DFTX Mind Medicine (MindMed) Inc. | 6,578 0.01% of outstanding | $62k | Mar 25, 2024 | $25k |
| Dec 26, 2023 | DFTX Mind Medicine (MindMed) Inc. | 6,774 0.02% of outstanding | $25k | Dec 26, 2023 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares10b5-1 | -10,853 | $36.57 | $397k | 792,846 | 14 d ago |
| Sep 14, 2026 | DFTX Mind Medicine (MindMed) Inc. | AGrant or award Common Shares | +200,000 | $0.00 | $0 | 803,699 | 29 d ago |
| Aug 12, 2026 | DFTX Mind Medicine (MindMed) Inc. | AGrant or award Common Shares | +100,000 | $0.00 | $0 | 603,282 | Aug 12, 2026 |
| Jun 25, 2026 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares10b5-1 | -10,035 | $45.03 | $452k | 503,282 | Jun 26, 2026 |
| Jun 22, 2026 | DFTX Mind Medicine (MindMed) Inc. | AGrant or award Common Shares | +100,000 | $0.00 | $0 | 513,317 | Jun 22, 2026 |
| Mar 25, 2026 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares10b5-1 | -8,018 | $18.47 | $148k | 413,317 | Mar 26, 2026 |
| Feb 3, 2026 | DFTX Mind Medicine (MindMed) Inc. | AGrant or award Common Shares | +150,000 | $0.00 | $0 | 575,025 | Feb 5, 2026 |
| Dec 26, 2025 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares10b5-1 | -5,600 | $13.15 | $74k | 425,025 | Dec 29, 2025 |
| Sep 25, 2025 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares10b5-1 | -7,704 | $9.77 | $75k | 430,625 | Sep 26, 2025 |
| Jun 25, 2025 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares10b5-1 | -7,848 | $6.80 | $53k | 438,329 | Jun 26, 2025 |
| Mar 25, 2025 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares10b5-1 | -6,836 | $6.74 | $46k | 446,177 | Mar 26, 2025 |
| Mar 12, 2025 | DFTX Mind Medicine (MindMed) Inc. | AGrant or award Common Shares | +115,000 | $0.00 | $0 | 453,013 | Mar 13, 2025 |
| Dec 26, 2024 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares10b5-1 | -6,643 | $7.43 | $49k | 338,013 | Dec 27, 2024 |
| Dec 26, 2023 | DFTX Mind Medicine (MindMed) Inc. | SOpen-market sale Common Shares | -6,774 | $3.63 | $25k | 365,030 | Dec 26, 2023 |
Questions about Dan Karlin
Answered from the filings on this page, as of the latest one.
Is Dan Karlin buying or selling?
In the last 12 months Dan Karlin reported 0 open-market buys worth $0 and 4 open-market sells worth $1.1M on SEC Form 4; the latest was sold $397k of DFTX on Sep 25, 2026. Grants, option exercises and tax withholding are not counted.
How did Dan Karlin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dan Karlin has 0.
Where does Dan Karlin file Form 4?
Dan Karlin has filed Form 4 at DFTX (Mind Medicine (MindMed) Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.